The growing kidney injury litigation involving Nexium and other proton pump inhibitors shows no signs of slowing down. Only last week, a new complaint was filed on behalf of an Ohio man who allegedly developed kidney failure due to his use of Nexium.
According to the September 16th filing in the U.S. District of Court, Southern District of Ohio, the Plaintiff was diagnosed with end stage renal disease (kidney failure) just months after he initiated treatment with Nexium to alleviate peptic disorders. The complaint alleges that AstraZeneca Pharmaceuticals LP and other Defendants “designed, researched, manufactured, tested, advertised, promoted, marketed, sold, and distributed Nexium. When warning of safety and risks of Nexium , Defendants negligently represented to the medical and healthcare community, the Food and Drug Administration (hereinafter referred to as the “FDA”), to Plaintiff and the public in general, that Nexium had been tested and was found to be safe and/or effective for its indicated use.”
Nexium is a proton pump inhibitor that reduces the amount of acid present in the stomach. According to the Ohio complaint, Nexium is AstraZeneca’s top selling medication, and the third largest selling drug on the global market. In 2005, AstraZeneca’s Nexium sales exceeded $5.7 billion. In 2008, sales topped $5.2 billion.
In 2013, some 15 million Americans took a proton pump inhibitor. Yet it is believed that up to 70% of these prescriptions lacked an appropriate indication.
According to the Ohio lawsuit, Nexium has been the subject of hundreds of adverse event reports made to the U.S. Food & Drug Administration, including reports of patients who had experienced kidney injuries while taking the drug as early as 1989. Several studies published in recent years have also linked these of proton pump inhibitors to kidney failure, chronic kidney disease and other renal complications.
“Defendants knew of the significant risk of kidney damage that could result from long-term Nexium use, but Defendants did not adequately and sufficiently warn consumers, including Plaintiff, his physician or the medical community in a timely manner,” the complaint charges.
Bernstein Liebhard LLP is representing plaintiffs in Nexium lawsuits involving kidney failure and other renal complications. To learn more, please call (888) 881-3077.